Transgenic mice expressing an α-secretion mutant of the amyloid precursor protein in the brain develop a progressive CNS disorder
- 28 August 1998
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 95 (1), 55-64
- https://doi.org/10.1016/s0166-4328(97)00210-6
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteinsNeuron, 1995
- Mutant and native human β-amyloid precursor proteins in transgenic mouse brainNeurobiology of Aging, 1995
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic miceNature Genetics, 1995
- Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic miceBrain Research, 1994
- Expression of APP in Brains of Transgenic Mice Containing the Entire Human APP GeneBiochemical and Biophysical Research Communications, 1993
- Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice.Proceedings of the National Academy of Sciences, 1993
- Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic miceNature Genetics, 1993
- Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.Proceedings of the National Academy of Sciences, 1992